Sabinsa Invites Noted Researcher to Discuss Role of Turmeric-Derived Curcuminoids in Treatment of Cancer at SupplySide West

PISCATAWAY, NJ, October 26, 2005 - Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, will be hosting a VendorWorks presentation entitled "Curcuminoids: Fighting Cancer Naturally" on Thursday, November 10, 2005 from 11 - 11:50 a.m. in the Bellini Ballroom room #2004 at the SupplySide West International Tradeshow and Conference at the Venetian Hotel & Sands Expo in Las Vegas, Nev.

Sabinsa has invited Shishir Shishodia, Ph.D., professor at Texas Southern University and researcher at M.D. Anderson Cancer Center, to discuss new research surrounding the role of turmeric-derived curcuminoids in the treatment of certain types of cancers. Curcuminoids are high-powered antioxidants that have been shown to block the chain of events leading to tumor development, progression and expansion. This session will review anti-cancer mechanisms, safety and toxicity and the numerous applications of curcuminoids in the treatment of cancer.

Dr. Shishodia earned his Ph.D. in Biotechnology from Banaras Hindu University (BHU), Varanasi, India, and conducted his postdoctoral fellowship at the University of Texas M. D. Anderson Cancer Center. His research interests include cytokine signaling, the role of transcription factors in tumorigenesis, and regulation of transcription by natural products. Dr.
Shishodia has identified several natural compounds that exhibit anti-cancer properties. He has published more than 50 peer-reviewed papers and edited a book on the role of Resveratrol in health and disease. Dr. Shishodia is also a recipient of the BHU Gold Medal and the Theodore N. Law Award for outstanding scientific achievements.

Curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin are collectively known as curcuminoids, and are recognized as one of the most promising food derived compounds in fighting cancer. Sabinsa Corporation provides an extract of turmeric standardized to 95 percent curcuminoids, Curcumin C3 Complex (R). Over the past several years, numerous studies have been funded by the National Institutes of Health to investigate the role of curcumin and its derivatives in treatment of patients with cancer.
Additionally, M.D. Anderson Cancer Center is involved in pre-clinical and clinical research of the anti-cancer mechanism and application of curcuminoids in conditions including multiple myeloma and colon cancer.

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals.
Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit <> or stop by booth #5000 at SupplySide West.

The SupplySide West trade show is dedicated to bringing together manufacturers and suppliers in the dietary supplement, food, pharmaceutical and cosmetic industries. The event provides a unique opportunity for an executive level exchange of ideas, goods and services not available through other any other business-to-business event. SupplySide West offers three days of informative seminars and exhibitions tailored to the specific needs of supply chain executives. For more information visit

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.